4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Cardiovascular Pharmacology and Therapeutics
Cardiovascular pharmacology and therapeutics form the backbone of managing heart-related conditions through targeted drug development and clinical applications. Medications like beta-blockers, ACE inhibitors, and antiplatelet agents play a critical role in treating hypertension, heart failure, and coronary artery disease. Advances in this field have led to novel therapeutics, including sodium-glucose cotransporter-2 (SGLT2) inhibitors and PCSK9 inhibitors, which offer new hope for patients with complex cardiovascular conditions. Ongoing research focuses on personalized medicine, exploring how genetic factors influence drug response to optimize treatment strategies. By blending pharmacology with innovative therapies, this field aims to improve cardiovascular outcomes while minimizing side effects.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Miroslav Radenkovic
University of Belgrade, Serbia
Syed Raza
Awali Hospital, Bahrain
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Characterizing cardiac ECG and echocardiographic abnormalities in cirrhotic patients with and without heart failure
Ishan Abdullah, George Washington University School of Medicine and Health Sciences, United States